MNPR · Monopar Therapeutics · Executive Compensation
Market Cap
$727.06M
Shares
6.71M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Chandler D. Robinson | Chief Executive Officer and Director | $10,637,821 |
| Andrew J. Cittadine | Chief Operating Officer | $4,706,431 |
| Quan Vu | Chief Financial Officer, Secretary, and Treasurer | $2,101,314 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Chandler D. Robinson | Chief Executive Officer and Director | $1,144,480 |
| Andrew J. Cittadine | Chief Operating Officer | $554,796 |
| Karthik Radhakrishnan | Former Chief Financial Officer, Secretary, and Treasurer | $320,160 |
| Quan Vu | Chief Financial Officer, Secretary, and Treasurer | — |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Chandler D. Robinson | Chief Executive Officer and Director | $1,778,667 |
| Andrew J. Cittadine | Chief Operating Officer | $911,161 |
| Kim R. Tsuchimoto | Former Chief Financial Officer, Secretary, and Treasurer and Director | $848,441 |
| Karthik Radhakrishnan | Former Chief Financial Officer, Secretary, and Treasurer | — |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Chandler D. Robinson | Chief Executive Officer and Director | $1,601,448 |
| Andrew J. Cittadine | Chief Operating Officer | $752,326 |
| Kim R. Tsuchimoto | Former Chief Financial Officer, Secretary, and Treasurer and Director | $695,128 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Chandler D. Robinson | MD, Chief Executive Officer and Director | $1,588,564 |
| Andrew P. Mazar | Ph.D., Executive Vice President of Research & Development, Chief Scientific Officer and Director | $872,571 |
| Kim R. Tsuchimoto | Chief Financial Officer | $523,349 |
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| Chandler D. Robinson | MD, Chief Executive Officer and Director | $541,250 |
| Andrew P. Mazar | Ph.D., Executive Vice President of Research & Development, Chief Scientific Officer and Director | $465,500 |
| Kim R. Tsuchimoto | Chief Financial Officer | $183,225 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Quan Vu | principal financial officer | Appointed | 2025-03-03 |
| Quan Vu | Chief Financial Officer | Appointed | 2025-03-03 |
| Quan Vu | principal accounting officer | Appointed | 2025-03-03 |
| Karthik Radhakrishnan | Chief Financial Officer | Terminated | 2025-03-03 |
| Lavina Talukdar | Board | Appointed | 2025-02-24 |
| Michael J. Brown | member of the Board of Directors | Resigned | 2025-02-24 |
| Karthik Radhakrishnan | Chief Financial Officer | Appointed | 2024-05-24 |
| Kim R. Tsuchimoto | Chief Financial Officer | Retired | 2024-05-24 |